Sarcomatoid larynx carcinoma differential clinical evolution, on field statistical considerations.
Larynx
Spidle cell carcinoma
Squamous cell carcinoma
Statistical analysis
Survival
Journal
American journal of otolaryngology
ISSN: 1532-818X
Titre abrégé: Am J Otolaryngol
Pays: United States
ID NLM: 8000029
Informations de publication
Date de publication:
Historique:
received:
14
12
2020
revised:
13
01
2021
accepted:
14
01
2021
pubmed:
3
2
2021
medline:
13
10
2021
entrez:
2
2
2021
Statut:
ppublish
Résumé
Spindle cell larynx carcinoma (SpCC) represents around 3% of laryngeal cancers. It is originated by a single cancer stem cell undergoing epithelial to mesenchymal transition. This explains the aggressiveness, the peculiar resistance to conventional therapy and the frequent relapses. We focused on this particular cancer subset characteristics in patients, in early and advanced stages primarily aiming to define and highlight the differences with Laryngeal Squamous Cell Carcinoma (LSCC) focusing on clinical features, treatments, follow-up and survival in a patient's cohort composed by comparable cases from two subgroups.
Identifiants
pubmed: 33526270
pii: S0196-0709(21)00035-1
doi: 10.1016/j.amjoto.2021.102934
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102934Informations de copyright
Copyright © 2021. Published by Elsevier Inc.